2026-525968-18-00Not yet recruitingPhase 4
iSGLT2 in permanent atrial fibrillation, heart failure with preserved ejection fraction and intermediate NT-proBNP values: randomized clinical trial
Source: EU CTIS (euclinicaltrials.eu) · Last updated 30 Sept 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 125 (estimated)
- First submitted
- 23 Jun 2026
- Start date
- 1 Sept 2026
- Lead sponsor
- Institut D Investigacio Sanitaria Pere Virgili
- Diseases
- Heart failure, Atrial fibrillation
- EU CT number
- 2026-525968-18-00
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 125
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Salut Sant Joan de Reus Coordinator of this site? Confirm its status | Reus | Spain | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.